1997
DOI: 10.1002/(sici)1096-9896(199704)181:4<362::aid-path764>3.3.co;2-p
|View full text |Cite
|
Sign up to set email alerts
|

bcl‐2 EXPRESSION IN PLEURAL AND EXTRAPLEURAL SOLITARY FIBROUS TUMOURS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
39
2
1

Year Published

2000
2000
2010
2010

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 39 publications
(44 citation statements)
references
References 0 publications
2
39
2
1
Order By: Relevance
“…Uniquely in this anatomic site, SFT reacts with vimentin, CD34, bcl-2, and CD99. The combination of bcl-2 and CD34 has been reported to be consistently identified in SFT, a finding helpful in establishing the diagnosis [18,19]. CD34 is a cell adhesion transmembrane glycoprotein found on the surface of many cells, showing myofibroblastic differentiation, hematologic progenitor cells, vascular endothelium, and dendritic cells.…”
Section: Discussionmentioning
confidence: 96%
“…Uniquely in this anatomic site, SFT reacts with vimentin, CD34, bcl-2, and CD99. The combination of bcl-2 and CD34 has been reported to be consistently identified in SFT, a finding helpful in establishing the diagnosis [18,19]. CD34 is a cell adhesion transmembrane glycoprotein found on the surface of many cells, showing myofibroblastic differentiation, hematologic progenitor cells, vascular endothelium, and dendritic cells.…”
Section: Discussionmentioning
confidence: 96%
“…In fact, in the case series of Hanau [14], the percentage of Ki-67 positive nuclei was low in all benign SFTs with values of 0-2%, while histologically malignant and highly cellular tumours showed higher nuclear scores (mean 30%, range 20-40%). Chilosi et al [6] reported no proliferative potential in benign SFT, but no data were provided for malignant SFTs.…”
Section: Discussionmentioning
confidence: 99%
“…The reason for this extensive heterogeneity is presently unknown. This finding is also relevant since cdk6 is a kinase that is overexpressed in T-cell [2] and myeloid leukemias and its characterization could provide useful information on the complexity of cell cycle derangement occurring in these malignancies.…”
Section: -D Mapping Of Mantle Cell Lymphomamentioning
confidence: 99%
“…These findings suggest that the integrated analysis of the discrete array of molecules involved in the cell cycle regulation and the "p53 pathway" may provide relevant information regarding tumor response in vivo, and may supply clinically useful information at the single patient level. The analysis of the molecular repertoire of a neoplastic cell population can be practically obtained by different methodological approaches, including extensive immunophenotypical analysis of tissues sections, expression analysis by complex molecular array systems based on the measurement of mRNA expression levels in target cells, and also by proteome analysis [1][2][3][4]. All these approaches are potentially able to provide a large number of data, which can be related to different lymphoma entities and their clinical features.…”
Section: Introductionmentioning
confidence: 99%